GO:0004105 choline-phosphate cytidylyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004105 choline-phosphate cytidylyltransferase activity is a molecular function that catalyzes the conversion of choline phosphate and CTP to CDP-choline and pyrophosphate, the rate-limiting step in phosphatidylcholine synthesis.
• The enzyme is highly regulated by glucocorticoids in fetal lung, where dexamethasone increases activity without changing protein amount, indicating post-translational control [1,5].
• Fatty acids stimulate microsomal CTP:choline phosphate cytidylyltransferase through a kinetic mechanism that alters substrate affinity.
• In plants, the enzyme is controlled by phosphorylation and other mechanisms, as shown in pea (Pisum sativum).
• De novo phosphatidylcholine synthesis, dependent on this activity, is required for autophagosome membrane formation and maintenance during autophagy.
• In cancer, phosphatidylcholine secreted by enzalutamide-resistant STEAP4+ myofibroblasts promotes stemness and progression in prostate cancer.
Description
Choline-phosphate cytidylyltransferase (EC 2.7.7.15) is the enzyme responsible for the committed step in the CDP-choline pathway, also known as the Kennedy pathway, for phosphatidylcholine biosynthesis. This activity, annotated as GO:0004105, catalyzes the transfer of a cytidylyl group from CTP to choline phosphate, yielding CDP-choline and pyrophosphate. Because phosphatidylcholine is the major phospholipid in eukaryotic membranes, this activity is essential for membrane biogenesis, lipoprotein secretion, and cell signaling. Researchers study this enzyme to understand how membrane lipid synthesis is coordinated with cell growth, autophagy, and stress responses. In fetal lung, glucocorticoids such as dexamethasone stimulate choline-phosphate cytidylyltransferase activity, a process critical for surfactant production and lung maturation [1,5]. The enzyme is also a target of regulation by fatty acids and phosphorylation, making it a focal point for understanding lipid metabolic control [6,3]. In cancer, altered phosphatidylcholine metabolism, including changes in this activity, contributes to tumor progression and therapy resistance.
choline-phosphate cytidylyltransferase activity At A Glance
| GO ID | GO:0004105 |
|---|---|
| GO term | choline-phosphate cytidylyltransferase activity |
| Ontology | Molecular function (biological_process aspect per QuickGO) |
| Synonym | None listed in QuickGO |
| Major function | Catalyzes the formation of CDP-choline from choline phosphate and CTP, the rate-limiting step in phosphatidylcholine synthesis |
| EC number | 2.7.7.15 |
| Substrates | Choline phosphate (phosphocholine) and CTP |
| Products | CDP-choline and pyrophosphate |
| Pathway | CDP-choline (Kennedy) pathway for phosphatidylcholine biosynthesis |
| Regulation | Stimulated by glucocorticoids in fetal lung [1,5]; activated by fatty acids; controlled by phosphorylation in plants |
What Is GO:0004105?
Choline-phosphate cytidylyltransferase activity (GO:0004105) is the catalytic function that transfers a cytidine monophosphate (CMP) moiety from CTP to choline phosphate (also called phosphocholine), producing CDP-choline and releasing pyrophosphate. This reaction is the rate-limiting and committed step in the synthesis of phosphatidylcholine via the CDP-choline pathway. The activity is found in both soluble and membrane-associated forms and is subject to regulation by lipids, phosphorylation, and hormones [6,1].
Why Is choline-phosphate cytidylyltransferase activity Important in Cell Biology?
Choline-phosphate cytidylyltransferase activity is critical because it governs the rate of phosphatidylcholine synthesis, which is required for membrane biogenesis, cell proliferation, and autophagy [8,2]. Dysregulation of this activity has been linked to cancer progression, where phosphatidylcholine secreted by stromal cells promotes stemness in prostate cancer. In fetal lung, glucocorticoid-induced increases in this activity are essential for surfactant production and neonatal survival [1,5]. Understanding its regulation provides insights into metabolic control and potential therapeutic targets for cancer and lung disease.
• Rate-limiting step in phosphatidylcholine synthesis, essential for membrane formation.
• Required for autophagosome membrane formation and maintenance during autophagy.
• Glucocorticoid-stimulated activity in fetal lung is critical for surfactant production [1,5].
• Fatty acids stimulate the enzyme, linking lipid availability to membrane synthesis.
• In plants, the enzyme is regulated by phosphorylation, affecting growth and development.
• Phosphatidylcholine secreted by cancer-associated fibroblasts promotes prostate cancer stemness.
• Dexamethasone increases activity without changing protein amount, indicating post-translational regulation.
• Glucocorticoid induction of fatty-acid synthase mediates stimulation of this activity.
• Altered choline-phosphate cytidylyltransferase activity contributes to metabolic reprogramming in cancer.
• The enzyme is a potential target for modulating membrane lipid composition in disease.
Molecular Mechanism of choline-phosphate cytidylyltransferase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs choline phosphate and CTP, then joins them to make CDP-choline.
Choline-phosphate cytidylyltransferase binds choline phosphate and CTP in an ordered or random mechanism, transferring the cytidylyl group to choline phosphate to form CDP-choline and pyrophosphate. The reaction is the committed step in phosphatidylcholine synthesis.
Fatty Acid Stimulation
In simple terms: Fatty acids turn the enzyme on by changing how it works.
Microsomal CTP:choline phosphate cytidylyltransferase is stimulated by fatty acids through a kinetic mechanism that increases substrate affinity, as shown by Weinhold et al.. This links lipid availability to membrane phospholipid synthesis.
Glucocorticoid Regulation in Fetal Lung
In simple terms: Hormones like dexamethasone boost the enzyme's activity in developing lungs.
In fetal rat lung, glucocorticoids stimulate choline-phosphate cytidylyltransferase activity via receptor-mediated responses. Dexamethasone increases activity without increasing the amount of enzyme protein, indicating post-translational activation. This stimulation is mediated in part by glucocorticoid induction of fatty-acid synthase.
Regulation by Phosphorylation in Plants
In simple terms: In plants, adding phosphate groups to the enzyme controls its activity.
In pea (Pisum sativum), CTP:choline-phosphate cytidylyltransferase activity is controlled by phosphorylation and other mechanisms, as demonstrated by Price-Jones et al.. This suggests conserved regulatory principles across eukaryotes.
Role in Autophagy
In simple terms: The enzyme helps build the membranes that cells use to recycle their own parts.
De novo phosphatidylcholine synthesis, dependent on choline-phosphate cytidylyltransferase activity, is required for autophagosome membrane formation and maintenance during autophagy. Inhibition of this pathway impairs autophagic flux.
Key Genes Involved in GO:0004105 choline-phosphate cytidylyltransferase activity
The following genes and proteins are directly involved in or regulate choline-phosphate cytidylyltransferase activity and the CDP-choline pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCYT1A | Encodes CTP:phosphocholine cytidylyltransferase alpha, the main enzyme for phosphatidylcholine synthesis | Target for studying membrane lipid synthesis and autophagy [2,8] |
| PCYT1B | Encodes CTP:phosphocholine cytidylyltransferase beta, a brain-specific isoform | Potential role in neuronal membrane metabolism |
| CEPT1 | Choline/ethanolamine phosphotransferase 1, catalyzes the final step of phosphatidylcholine synthesis | Downstream of CDP-choline; studied in lipid metabolism |
| CHKA | Choline kinase alpha, phosphorylates choline to choline phosphate | Upstream of cytidylyltransferase; target in cancer |
| CHKB | Choline kinase beta, phosphorylates choline | Related to muscle function and lipid metabolism |
| STEAP4 | Metalloreductase expressed in cancer-associated fibroblasts | Secretes phosphatidylcholine to promote prostate cancer stemness |
| NR3C1 | Glucocorticoid receptor, mediates dexamethasone stimulation of cytidylyltransferase | Key regulator in fetal lung maturation [1,5] |
| FASN | Fatty acid synthase, induced by glucocorticoids | Mediates stimulation of cytidylyltransferase activity |
| PPARGC1A | PGC-1alpha, regulates lipid metabolism | Potential upstream regulator of phosphatidylcholine synthesis |
| SREBF1 | Sterol regulatory element-binding transcription factor 1 | Regulates lipogenic genes including FASN |
| LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Remodels phosphatidylcholine; affects membrane composition |
| PLA2G4A | Phospholipase A2, releases fatty acids from phospholipids | Provides fatty acids that stimulate cytidylyltransferase |
| ABCA1 | ATP-binding cassette transporter A1 | Lipid efflux; linked to phosphatidylcholine metabolism |
| LCAT | Lecithin-cholesterol acyltransferase | Uses phosphatidylcholine as substrate; related to lipoprotein metabolism |
| PEMT | Phosphatidylethanolamine N-methyltransferase | Alternative pathway for phosphatidylcholine synthesis |
| CDS1 | CDP-diacylglycerol synthase 1 | Competes for CDP-choline? No, uses CTP for CDP-DAG; related to lipid metabolism |
| ETNK1 | Ethanolamine kinase 1 | Phosphorylates ethanolamine; parallel pathway |
| PCYT2 | CTP:phosphoethanolamine cytidylyltransferase | Parallel enzyme in phosphatidylethanolamine synthesis |
How Is choline-phosphate cytidylyltransferase activity Regulated?
Choline-phosphate cytidylyltransferase activity is regulated at multiple levels. In fetal lung, glucocorticoids such as dexamethasone increase activity without changing protein amount, indicating post-translational activation. This stimulation is mediated by glucocorticoid induction of fatty-acid synthase. Fatty acids directly stimulate the microsomal enzyme through a kinetic mechanism. In plants, the enzyme is controlled by phosphorylation. Additionally, the enzyme is regulated by membrane lipid composition and phosphorylation by AMP-activated protein kinase and other kinases, though specific pathways may vary by cell type.
choline-phosphate cytidylyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCYT1A | Cancer, autophagy defects | Knockout in cancer cell lines; autophagy flux assays |
| STEAP4 | Prostate cancer progression | Overexpression in myofibroblasts; co-culture with prostate cancer cells |
| NR3C1 | Lung maturation disorders | Knockout in fetal lung explants; dexamethasone treatment [1,5] |
| FASN | Metabolic disorders, cancer | Point mutation to disrupt glucocorticoid induction |
| CHKA | Cancer metabolism | Knockout in tumor cells; lipidomics |
Cancer Progression and Therapy Resistance
In prostate cancer, enzalutamide-resistant STEAP4+ myofibroblasts secrete phosphatidylcholine, which activates stemness and fosters progression in hormone-sensitive prostate cancer. This highlights how altered phosphatidylcholine metabolism, potentially involving choline-phosphate cytidylyltransferase activity, contributes to therapy resistance.
Autophagy and Neurodegeneration
De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy. Defects in this pathway could impair autophagic clearance, which is implicated in neurodegenerative diseases, though direct links to choline-phosphate cytidylyltransferase activity require further study.
Lung Maturation and Respiratory Distress
Glucocorticoid-stimulated choline-phosphate cytidylyltransferase activity in fetal lung is critical for surfactant production [1,5]. Insufficient activity may contribute to respiratory distress syndrome in premature infants, although direct evidence in humans is limited.
From choline-phosphate cytidylyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PCYT1A impair autophagy? | PCYT1A knockout cell line; LC3 flux assay |
| How does dexamethasone stimulate cytidylyltransferase? | Point mutation of phosphorylation sites; fetal lung cells |
| Does STEAP4-secreted phosphatidylcholine promote stemness? | STEAP4 overexpression in fibroblasts; co-culture |
| What is the role of fatty acid stimulation? | Knock-in of mutant enzyme with altered lipid binding |
| Can we tag endogenous PCYT1A for localization? | Knock-in of fluorescent tag at PCYT1A locus |
| Does PCYT1A overexpression increase phosphatidylcholine? | Overexpression in cell lines; lipidomics |
How to Study the choline-phosphate cytidylyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioenzymatic assay | CDP-choline formation from labeled substrates | Direct measurement of enzyme activity |
| Lipidomics (LC-MS) | Phosphatidylcholine and intermediate levels | Assessing pathway flux in cells |
| Western blot | Protein expression of PCYT1A and related enzymes | Validating knockout or overexpression |
| LC3 flux assay | Autophagosome formation and degradation | Linking enzyme to autophagy |
| qRT-PCR | mRNA levels of PCYT1A and regulators | Studying transcriptional regulation |
| Phosphorylation-specific antibodies | Phosphorylation status of cytidylyltransferase | Investigating post-translational control |
| CRISPR knockout | Loss-of-function phenotypes | Determining gene essentiality |
| Overexpression | Gain-of-function effects | Testing sufficiency in lipid synthesis |
Enzymatic Activity Assays
Choline-phosphate cytidylyltransferase activity is typically measured using radiolabeled choline phosphate and CTP, followed by separation of CDP-choline by thin-layer chromatography or HPLC [6,1]. This method quantifies the rate of CDP-choline formation.
Lipidomics and Metabolomics
Mass spectrometry-based lipidomics can measure phosphatidylcholine and its precursors to infer flux through the CDP-choline pathway [4,8]. This is useful for assessing how genetic or pharmacological perturbations affect lipid metabolism.
Autophagy Flux Assays
Autophagosome formation and maintenance can be monitored using LC3-II western blotting or fluorescent reporters in cells with modulated cytidylyltransferase activity. This links the enzyme to autophagic processes.
Gene Expression and Regulation Studies
Quantitative RT-PCR, western blotting, and promoter-reporter assays are used to study how glucocorticoids and other factors regulate PCYT1A expression and activity [1,5,7].
How CRISPR Can Be Used to Study GO:0004105 choline-phosphate cytidylyltransferase activity
Knockout
CRISPR knockout of PCYT1A or related genes can abolish choline-phosphate cytidylyltransferase activity, leading to impaired phosphatidylcholine synthesis and autophagy defects. Such models are valuable for studying the essentiality of this pathway in cell proliferation and survival.
Point Mutation
Point mutations can be introduced to disrupt specific regulatory sites, such as phosphorylation residues or lipid-binding domains, to dissect how post-translational modifications control enzyme activity [5,6]. This allows precise interrogation of regulatory mechanisms.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous PCYT1A locus enables real-time imaging and proteomic analysis of the enzyme in its native context. This approach preserves endogenous regulation.
Overexpression
Overexpression of PCYT1A or activating mutants can increase phosphatidylcholine synthesis and may promote membrane expansion or autophagy [2,8]. This is useful for gain-of-function studies and for testing therapeutic hypotheses.
How EDITGENE Supports choline-phosphate cytidylyltransferase activity Research
Researchers studying choline-phosphate cytidylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, autophagy, or cancer progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for choline-phosphate cytidylyltransferase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PCYT1B Knockout HEK293 Cell Line | EDJ-KQ6596 | Human | 9468 | Details Get a Quote |
| PCYT1B Knockout HeLa Cell Line | EDJ-KQ55173 | Human | 9468 | Details Get a Quote |
| PCYT1B Knockout A-549 Cell Line | EDJ-KQ63653 | Human | 9468 | Details Get a Quote |
| PCYT1B Knockout HCT 116 Cell Line | EDJ-KQ72113 | Human | 9468 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About choline-phosphate cytidylyltransferase activity
What is choline-phosphate cytidylyltransferase activity?
It is the enzymatic activity that converts choline phosphate and CTP to CDP-choline, the rate-limiting step in phosphatidylcholine synthesis.
What genes are involved in choline-phosphate cytidylyltransferase activity?
Key genes include PCYT1A and PCYT1B, which encode the enzyme isoforms, as well as upstream regulators like CHKA and NR3C1 [8,1].
How is choline-phosphate cytidylyltransferase activity regulated?
It is regulated by glucocorticoids, fatty acids, and phosphorylation, with dexamethasone increasing activity without changing protein levels [1,5,6,3].
What diseases are associated with choline-phosphate cytidylyltransferase activity?
Altered activity has been linked to cancer progression, autophagy defects, and lung maturation disorders [4,2,1].
What is the role of choline-phosphate cytidylyltransferase in autophagy?
De novo phosphatidylcholine synthesis, dependent on this activity, is required for autophagosome membrane formation and maintenance.
How can I measure choline-phosphate cytidylyltransferase activity?
Radioenzymatic assays using labeled choline phosphate and CTP are standard, along with lipidomics to assess pathway flux [6,4].
What cell models are available for studying this activity?
CRISPR knockout, point mutation, knock-in, and overexpression models can be generated in various cell lines [2,5,8].
Is choline-phosphate cytidylyltransferase a good drug target?
It is a potential target for modulating membrane lipid synthesis in cancer and metabolic diseases, though further validation is needed [4,8].
What is the CDP-choline pathway?
The CDP-choline or Kennedy pathway is the main route for phosphatidylcholine synthesis, with choline-phosphate cytidylyltransferase as the committed step.
How does dexamethasone affect choline-phosphate cytidylyltransferase?
Dexamethasone increases enzyme activity in fetal lung without increasing protein amount, indicating post-translational activation.
Conclusion
Choline-phosphate cytidylyltransferase activity (GO:0004105) is a central node in phosphatidylcholine biosynthesis, influencing membrane biogenesis, autophagy, and cancer progression [8,2,4]. Its regulation by glucocorticoids, fatty acids, and phosphorylation underscores its importance in metabolic control [1,5,6,3]. Continued research using advanced CRISPR models will further elucidate its roles in health and disease.
References
- 1. Rooney SA et al.. 1986. Glucocorticoid stimulation of choline-phosphate cytidylyltransferase activity in fetal rat lung: receptor-response relationships.. Biochim Biophys Acta 888(2):208-16 PMID: 3017448
- 2. Andrejeva G et al.. 2020. De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy.. Autophagy 16(6):1044-1060 PMID: 31517566
- 3. Price-Jones MJ et al.. 1986. The control of CTP:choline-phosphate cytidylyltransferase activity in pea (Pisum sativum L.).. Biochem J 240(3):837-42 PMID: 3030288
- 4. Wang W et al.. 2025. Enzalutamide-Resistant STEAP4(+) MyoCAF Secrete Phosphatidylcholine to Foster Progression by Activating Stemness in Hormone-Sensitive Prostate Cancer.. Adv Sci (Weinh) 12(44):e10602 PMID: 40917018
- 5. Rooney SA et al.. 1990. Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung.. Biochim Biophys Acta 1044(3):385-9 PMID: 2163682
- 6. Weinhold PA et al.. 1991. Microsomal CTP:choline phosphate cytidylyltransferase: kinetic mechanism of fatty acid stimulation.. Biochim Biophys Acta 1086(1):57-62 PMID: 1659454
- 7. Xu ZX et al.. 1990. Glucocorticoid induction of fatty-acid synthase mediates the stimulatory effect of the hormone on choline-phosphate cytidylyltransferase activity in fetal rat lung.. Biochim Biophys Acta 1044(1):70-6 PMID: 2160286
- 8. Fagone P et al.. 2013. Phosphatidylcholine and the CDP-choline cycle.. Biochim Biophys Acta 1831(3):523-32 PMID: 23010477
